Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: A comparative pilot study -Results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study
<p>Abstract</p> <p>Objective</p> <p>To evaluate glycemic variability associated with two different premixed insulin analogue formulations when used in a twice-daily regimen.</p> <p>Patients and Methods</p> <p>Subjects comprised type 2 diabetic pa...
Main Authors: | Morimoto Aya, Taki Kentaro, Tsujino Daisuke, Nishimura Rimei, Tajima Naoko |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://www.cardiab.com/content/9/1/16 |
Similar Items
-
Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes
by: Zafar MI, et al.
Published: (2014-12-01) -
Humalog Mix 25 in the treatment of type 2 diabetes mellitus
by: Vladimir Ivanovich Zoloedov, et al.
Published: (2012-06-01) -
Ultra‐Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog® in Japanese patients with type 1 diabetes
by: Masanari Shiramoto, et al.
Published: (2020-05-01) -
Meeting of the expert committee on the use of pre-mixed insulin preparation Humalog Mix 50 in type 2 diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2013-12-01) -
Effects of Exenatide and Humalog Mix25 on Fat Distribution, Insulin Sensitivity, and β-Cell Function in Normal BMI Patients with Type 2 Diabetes and Visceral Adiposity
by: Xinlei Wang, et al.
Published: (2020-01-01)